Astex Pharmaceuticals Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Astex Pharmaceuticals Inc. - overview
Established
1999
Location
Cambridge, -, UK
Primary Industry
Pharmaceuticals
About
Founded in 1999 and based in Cambridge, UK, Astex Pharmaceuticals Inc. is a biotechnology company that develops small molecule therapeutics for the treatment of cancer using a fragment-based drug discovery platform Pyramid. The company is formerly known as Astex Therapeutics and changed its name to Astex Pharmaceuticals Inc. in April 2011 through a merger with SuperGen, Inc.
Current Investors
Abingworth, Advent International, Alta Partners
Primary Industry
Pharmaceuticals
Sub Industries
Oncology/Cancer Treatment, Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
http://www.astex-therapeutics.com
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.